NCT04033133View on ClinicalTrials.gov

Cerebral Blood Flow and tDCS

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

August 15, 2020

Study Completion Date

August 15, 2020

Conditions
Multiple Sclerosis
Interventions
DEVICE

tDCS

Subjects will get tDCS at intensities of 0, 1, 2, 3, and 4 mA.

Trial Locations (1)

52242

Department of Health and Human Physiology, Iowa City

All Listed Sponsors
lead

University of Iowa

OTHER

NCT04033133 - Cerebral Blood Flow and tDCS | Biotech Hunter | Biotech Hunter